ReviewDiabetes therapy : research, treatment and education of diabetes and related disorders2019

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice.

Amar Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.